164422_bioimage

Kelly F. Xiang

Kelly Xiang focuses her practice on cross-border matters involving China, including all forms of foreign direct investments in China, market entries, mergers and acquisitions, commercial franchising, labor and employment, immigration, taxes, licensing, regulatory issues, general corporate matters and IP-related matters including trademark, branding and licensing.

What do you focus on?

My combination of experience in both common law system and civil law system makes me the ideal lawyer for handling cross-border matters. I have advised U.S. or European companies in different industries in connection with their China operations, including entity formation, business related agreements and related employment, tax and immigration matters. In addition, I have advised U.S. companies selling their equity to Chinese companies, and acquiring equity, business or assets of Chinese companies. I also perform due diligence to identify and handle actual and potential legal liabilities and obstacles in the target company to ensure a successful acquisition. I team with our colleagues in the U.S. to assist Chinese or Asian companies with their investment into the U.S., providing clients with strategic advice on legal and tax structures.

What do you see on the horizon?

I’ve been following developments and trends of laws and regulations regarding inbound and outbound investments to ensure that my clients’ transactions are smooth and successful.

Publications

  • “New Foreign Representative Office Regulations Add More Burdens,” Nixon Peabody Alert, January 2011. (Coauthor)
  • “Shanghai on Its Way to Become Onshore RMB Market,” Nixon Peabody Alert, October 2010. (Coauthor)
  • “The Latest on Foreign Investment in China,” Law360, August 2010. (Coauthor)
  • “Taxation on Indirect Equity Transfers of a PRC Company,” Nixon Peabody Alert, August 2010. (Coauthor)
  • "“China’s MOFCOM Further Delegates Approval Authority to Local Levels,” Nixon Peabody Alert, August 2010. (Coauthor)

Deal Watch: Private equity hits new heights

The American Lawyer | November 22, 2021

This article on the surge in private equity deals includes NP for advising the owners of skin care brand Obagi in its $1.2 billion business combination agreement with Waldencast Acquisition Corp. and the spinoff of Obagi’s operations in China.

The NP team was led by David Cheng, chair and managing partner of the firm's China and Asia-Pacific practice, and New York City Corporate partners Michael Smith and Richard Langan. The team that advised Obagi also included Chicago Corporate partner David Brown, Rochester Corporate partner Jeremy Wolk, Washington, DC Complex Commercial Disputes partner and Antitrust team leader Gordon Lang, and Washington, DC Corporate senior counsel Kenneth Silverberg. Other members of the team included Boston Corporate associate Anthony Bova and Chinese legal consultant Kelly Xiang.

Four firms lead three-way SPAC to create new beauty platform

Bloomberg Law | November 18, 2021

This article covering a roughly $1.2 billion merger of skin care and beauty brands with a special purpose acquisition company mentions NP for advising the owners of skin care brand Obagi in its business combination agreement with Waldencast Acquisition Corp. and the spinoff of Obagi's operations in China.

The NP team was led by David Cheng, chair and managing partner of the firm's China and Asia-Pacific practice, and New York City Corporate partners Michael Smith and Richard Langan. The team that advised Obagi also included Chicago Corporate partner David Brown, Rochester Corporate partner Jeremy Wolk, Washington, DC Complex Commercial Disputes partner and Antitrust team leader Gordon Lang, and Washington, DC Corporate senior counsel Kenneth Silverberg. Other members of the team included Boston Corporate associate Anthony Bova and Chinese legal consultant Kelly Xiang.

Contact

Kelly F. Xiang

Chinese Legal Consultant

Shanghai

Phone: +86 21 6137 5500


Fax: +86 21 6137 5588

University of Hong Kong, MPhil, in Law

University of Macau, Postgraduate Program in Law

Peking University, M.A., B.A.

People's Republic of China

Mandarin Chinese

Back to top